InvestorsObserver
×
News Home

Is Zynex Inc. (ZYXI) a Good Buy in the Healthcare Sector?

Wednesday, November 01, 2023 12:13 PM | InvestorsObserver Analysts

Mentioned in this article

Is Zynex Inc. (ZYXI) a Good Buy in the Healthcare Sector?

Zynex Inc. (ZYXI) is around the top of the Healthcare sector according to InvestorsObserver. ZYXI received an overall rating of 48, which means that it scores higher than 48% of stocks. Additionally, Zynex Inc. scored a 88 in the Healthcare sector, ranking it higher than 88% of stocks in that sector.

Overall Score - 48
ZYXI has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on ZYXI!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 48 would rank higher than 48 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Zynex Inc. Stock Today?

Zynex Inc. (ZYXI) stock has fallen -0.68% while the S&P 500 is higher by 0.47% as of 12:07 PM on Wednesday, Nov 1. ZYXI is down -$0.06 from the previous closing price of $8.88 on volume of 109,979 shares. Over the past year the S&P 500 is higher by 9.27% while ZYXI is down -28.12%. ZYXI earned $0.43 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.43. Click Here to get the full Stock Report for Zynex Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App